NeoStem Inc. is engaged in a platform business of operating a commercial autologous adult stem cell bank and is pioneering the pre-disease collection processing and long-term storage of stem cells from adult donors.


Updates from The Motley Fool

Latest updates on Neostem from Fool.com.

There is no available coverage of Neostem at this time.



Stock Performance

View Interactive CLBS Charts
Sponsored by

Key Data Points

Primary metrics and data points about Neostem.
Current Price: $3.70
Prev Close: $3.80
Open: $3.80
Bid: $3.65
Ask: $4.68
Day's Range: $3.68 - $3.85
52wk Range: $2.65 - $7.79
Volume: 46,819
Avg Vol 33,269
Market Cap: $35M
P/E (ttm): -1.43
EPS (ttm): ($2.66)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Neostem.
CAPS Rating 1 out of 5
 
166 Outperform
14 Underperform
CAPS All Stars
 
11 Outperform
7 Underperform

How do you think Neostem will perform against the market?



You pick for Neostem is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

David J. Mazzo, CEO

100% Approve

Based on 1 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Neostem.

NeoStem Inc. is engaged in a platform business of operating a commercial autologous adult stem cell bank and is pioneering the pre-disease collection processing and long-term storage of stem cells from adult donors.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Healthcare IT